EverHint – Volatile High Beta – Top 5 Signals for Jun 24, 2026
Excerpt: 5 signals. Healthcare leads (4). price range $10-$747. 3 with insider selling.
What This Signal Is
High momentum stock screener for swing trading opportunities. Identifies stocks with strong momentum characteristics suitable for swing trading (1-4 week holds). Includes multiple variants: breakout, pullback, aggressive momentum, and volatile high-beta.
Entry Criteria:
- Strong RSI momentum (configurable thresholds)
- Volume surge above average
- Price momentum confirmation
- Minimum ADV: $25M+ (varies by variant)
- Earnings buffer: 7 days pre/post earnings
- Variant-specific filters applied
Holding period: 1-4 weeks | Risk level: Medium-High
Market Context
Markets are showing a mixed but relatively stable picture heading into today's session, with the major indices diverging in notable ways. The Dow's modest outperformance against a softer Nasdaq suggests investors are rotating toward more defensive and value-oriented names, while growth and technology-heavy assets face mild selling pressure. This kind of internal divergence is a classic setup for momentum-swing strategies, where the goal is to capture directional moves within a defined trend — the key is identifying which pockets of the market are gaining relative strength rather than chasing broad index moves.
Volatility, as measured by the VIX at 19.51, sits in a moderate zone — elevated enough to produce meaningful intraday price swings, but not so extreme as to create erratic, whipsaw conditions that can undermine swing setups. This level tends to be a sweet spot for momentum-swing signals, offering enough price movement to generate actionable entries and exits while keeping risk manageable. Traders should remain mindful that even small upticks in the VIX from here could widen bid-ask spreads and increase overnight gap risk, making position sizing discipline especially important.
Healthcare's emergence as the top sector for today's signals aligns well with the broader rotation story. When investors shift away from high-growth, rate-sensitive sectors, defensively oriented areas like healthcare tend to attract capital, creating sustained directional momentum rather than short-lived spikes. This sector rotation dynamic supports the reliability of momentum-swing setups in healthcare today, as the move is likely driven by genuine risk-appetite shifts rather than speculative noise — a more durable foundation for swing trades targeting multi-day price trends.
📊 Signals (5 of 5 total)
Ranked by composite momentum score (higher = stronger momentum)
| # | Ticker | Company | Sector | Price | Score | Insider | MCap |
|---|---|---|---|---|---|---|---|
| 1 | ABSI | Absci Corporation | Healthcare | $10.07 | 1.00 | -$1,760,501 | $1.6B |
| 2 | DFTX | Definium Therapeutics,... | Healthcare | $42.13 | 0.75 | — | $4.6B |
| 3 | GH | Guardant Health, Inc. | Healthcare | $136.96 | 0.50 | -$1,578,256 | $18.2B |
| 4 | IESC | IES Holdings, Inc. | Industrials | $747.49 | 0.25 | — | $14.9B |
| 5 | CNTA | Centessa Pharmaceutica... | Healthcare | $40.50 | 0.00 | -$836,142 | $6.3B |
Field Notes
Sector concentration: Healthcare (4), Industrials (1)
Insider selling: ABSI (Absci Corporation, -$1,760,501), GH (Guardant Health, Inc., -$1,578,256), CNTA (Centessa Pharmaceuticals plc, -$836,142)
Data coverage: 80.0% insider, 20.0% congressional, 0.0% earnings, 60.0% news
Peer Analysis
CNTA (Centessa Pharmaceuticals plc): Leads 5 peers: APGE ($132.69), XENE ($55.58), AAPG ($17.08), RARE ($29.11), CELC ($96.38)
IESC (IES Holdings, Inc.): Leads 5 peers: PRIM ($92.69), DY ($483.48), FLR ($53.17), TTEK ($28.58), AWI ($157.70)
DFTX (Definium Therapeutics, Inc.): Leads 5 peers: URGN ($35.42), TNGX ($29.12), ANAB ($58.48), RZLT ($5.03), XNCR ($14.45)
ABSI (Absci Corporation): Leads 5 peers: RGNX ($9.97), VSTM ($3.85), OLMA ($11.14), MLTX ($20.00), PRTA ($9.40)
GH (Guardant Health, Inc.): Leads 5 peers: ICLR ($158.17), RVTY ($105.63), ASND ($238.01), VTRS ($15.93), QGEN ($38.73)
Congressional Activity
GH (Guardant Health, Inc.) 🟢 Bullish
- 1 purchase by 1 member
Recent Headlines
ABSI (Absci Corporation)
- Absci Raises $100 Million In Equity To Fund AI-Designed Hair Loss And Endometriosis Program
- Absci Announces Pricing of $100 Million Underwritten Offering with Leading Strategic and Financial Investors
- Absci Announces Positive Interim Phase 1 Data from the HEADLINE™ Trial of ABS-201, a Novel Antibody Targeting the Prolactin Receptor (PRLR)
CNTA (Centessa Pharmaceuticals plc)
- Acquisition of Centessa by Lilly Approved by the High Court of Justice of England and Wales
DFTX (Definium Therapeutics, Inc.)
- Definium Therapeutics, Inc. (DFTX) Shareholder/Analyst Call Transcript
- Definium Shares Soar After Reporting Positive Phase 3 Results For Single-Dose Depression Treatment
- Definium Therapeutics Announces Positive Topline Results from Phase 3 Emerge Study of DT120 Orally Disintegrating Tablet (ODT) in Major Depressive Disorder
- Definium Therapeutics to Discuss Topline Results from Phase 3 Emerge Study in Major Depressive Disorder on June 22, 2026
Vlad's Take
Today's signals: Strong sector concentration in Healthcare (4 signals) suggests sector-specific rotation. 3 signals showing insider selling warrant caution.
Independent, data-driven signals.
No hype. No promotions. Just experimental market research from EverHint.
This is not financial advice. Market conditions change rapidly.
Do your own due diligence.
See https://www.everhint.com/disclaimer/ and https://www.everhint.com/faqs/
📢 Support the project by liking, sharing, or subscribing — it helps more readers discover these signals.